Silver Oak Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Buy
+535
New +$213K 0.09% 81
2025
Q4
– Sell
-1,371
Closed -$386K – 76
2025
Q3
$386K Sell
1,371
-2
-0.1% -$580 0.17% 53
2025
Q2
$383K Buy
1,373
+233
+20% +$66K 0.19% 51
2025
Q1
$355K Buy
1,140
+2
+0.2% +$591 0.19% 49
2024
Q4
$296K Sell
1,138
-8
-0.7% -$2.37K 0.16% 48
2024
Q3
$369K Buy
1,146
+10
+0.9% +$3.27K 0.19% 48
2024
Q2
$354K Buy
1,136
+2
+0.2% +$588 0.2% 47
2024
Q1
$323K Buy
1,134
+1
+0.1% +$293 0.18% 50
2023
Q4
$326K Sell
1,133
-6
-0.5% -$1.64K 0.19% 47
2023
Q3
$306K Buy
+1,139
New +$284K 0.2% 45

Other funds holding AMGN

Silver Oak Advisory Group's AMGN Position: Q3 2026 in Review

Silver Oak Advisory Group opened a new position in Amgen (AMGN) in Q3 2026: 535 shares worth $226K. The stake represents 0.09% of the portfolio and ranks #81 among its holdings. This is a return to the name: Silver Oak Advisory Group previously reported a position in AMGN as recently as Q3 2025.

Silver Oak Advisory Group first reported a position in AMGN in Q3 2023 and has held it in 10 quarters since. The position peaked at $386K in Q3 2025. 3,260 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Silver Oak Advisory Group held 535 shares of Amgen worth $226K as of Q3 2026.
  • Amgen was a new Silver Oak Advisory Group position in Q3 2026.
  • Amgen made up 0.09% of Silver Oak Advisory Group's portfolio in Q3 2026, its #81 holding.
  • Silver Oak Advisory Group first reported a position in Amgen in Q3 2023 and has held it in 10 quarters since.
  • Silver Oak Advisory Group's Amgen position peaked at $386K in Q3 2025.
  • 3,260 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Silver Oak Advisory Group's 13F filing for Q3 2026, filed 6 Nov 2026.